Skip to main content
OpenTrials
Completed

NCT Number: NCT02906592

Using a Geriatric Oncology Assessment to Link With Services

The objective of this study is to implement a brief geriatric oncology assessment (GOA) in a community-based oncology clinic, the Scotland Cancer Treatment Center - a clinic within the Duke Cancer Network, located in the rural, low resource Scotland County community of North Carolina. Secondly, the investigators will evaluate the effectiveness of the brief GOA by comparing historical and post-GOA service referral patterns and adherence to planned cancer therapy. For this study, the investigators will prospectively enroll up to 60 patients who have been diagnosed and/or treated for cancer to complete the brief GOA. In addition to these 60 patients, the investigators will also conduct retrospective chart reviews on 120 patients that would be eligible for this study to evaluate past referral patterns. Eligible and consented patients will complete the brief GOA at the Scotland Cancer Treatment Center alongside their normal clinic appointment. The investigators will assess impact on the healthcare system by evaluating referral patterns (i.e., how many, what type of services) using the brief GOA data and EHR data. The study value includes the possibility for recognition and access to additional health care referrals if needed.

Completed

Looking for future studies?

Notify Me

Key information

Conditions

Cancer Neoplasms

Age range

60 year and older

Sex eligibility

All sexes

Study type

Observational

Primary location

Scotland Cancer Treatment Center

Laurinburg, North Carolina, 28352, United States

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

In order to be included in the project, patients must be:

  • Diagnosed for a solid tumor cancer (breast, lung, colon, rectal, colorectal (unspecified), pancreas, esophageal)
  • Diagnosis date within 12 months of identification
  • Receiving care at Scotland Cancer Treatment Center
  • Aged 60 years or older at the time of the visit
  • Planned therapy in the medical oncology clinic at the Scotland Cancer Treatment Center

Exclusion criteria

  • Diagnosis of metastatic cancer with <12 months life expectancy
  • Planned cancer therapy as surgery only
  • Receiving palliative or hospice care services (i.e., proxy for <12 months life expectancy)
  • Language (not proficient in English)
  • Nursing home/long-term care facility resident
  • Active diagnosis of psychosis (has been hospitalized in the last 30 days), schizophrenia, severe intellectual or developmental disabilities, or dementia
  • Patient deemed not fit/good candidate for study per provider recommendation

Treatment and study plan

Primary outcomes

  1. Change in referral patterns

    Time frame: retrospective data from 1/1/2013-7/7/2016

    Comparison of historical and post GOA service referral patterns

  2. Time to complete the brief GOA

    Time frame: 6 months

  3. Number of referrals completed

    Time frame: 6 months

  4. Number of patients who needed help completing the brief GOA

    Time frame: 6 months

Sponsors and collaborators

Lead sponsor

Duke University

Other

Collaborators

  • Duke Cancer Institute

Registry information

Official study title

Using a Geriatric Oncology Assessment to Link With Services (GOAL)

Acronym: GOAL

Important dates

Study start
2017
Primary completion
2017
Study completion
2017
First posted
Sep 20, 2016
Registry last updated
Jan 11, 2018

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Related clinical trials

Published trials that share one or more normalized conditions with this study.